Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Anebulo Pharmaceuticals, Inc. (ANEB)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-22Jun-30-21Jun-30-20
   10-K10-K8-K
Revenues  0.00.00.2
            Revenue growth   -100.0% 
Cost of goods sold  0.00.00.2
Gross profit  0.00.00.0
            Gross margin    -15.6%
Selling, general and administrative   [+]3.91.30.0
Research and development  3.02.3 
Other operating expenses    0.1
EBIT   [+]-6.8-3.6-0.2
            EBIT margin    -115.6%
Interest expense, net   [+]0.00.00.0
Other income (expense), net   [+]0.0-26.6 
Pre-tax income  -6.8-30.3-0.2
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -6.8-38.5-0.2
            Net margin    -116.4%
   
Basic EPS   [+]($0.29)($2.83)($0.01)
Diluted EPS   [+]($0.29)($2.83)($0.01)
   
Shares outstanding (basic)   [+]23.313.612.0
Shares outstanding (diluted)   [+]23.313.612.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy